These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20979454)

  • 81. Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.
    He XS; Holmes TH; Sanyal M; Albrecht RA; García-Sastre A; Dekker CL; Davis MM; Greenberg HB
    J Infect Dis; 2015 Apr; 211(7):1051-9. PubMed ID: 25336731
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
    Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
    Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Vaccination strategies to protect children against seasonal and pandemic influenza.
    Rimmelzwaan GF; Bodewes R; Osterhaus AD
    Vaccine; 2011 Oct; 29(43):7551-3. PubMed ID: 21820479
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Phase IV: randomized controlled trial to evaluate lot consistency of trivalent split influenza vaccines in healthy adults.
    Song JY; Cheong HJ; Lee J; Wie SH; Park KH; Kee SY; Jeong HW; Kim YS; Noh JY; Choi WS; Park DW; Sohn JW; Kim WJ
    Hum Vaccin Immunother; 2014; 10(10):2958-64. PubMed ID: 25483462
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
    Gorse GJ; Falsey AR; Fling JA; Poling TL; Strout CB; Tsang PH
    Vaccine; 2013 May; 31(19):2358-65. PubMed ID: 23499604
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.
    Broadbent AJ; Subbarao K
    Curr Opin Virol; 2011 Oct; 1(4):254-62. PubMed ID: 22125588
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010.
    Goh EH; Jiang L; Hsu JP; Tan LWL; Lim WY; Phoon MC; Leo YS; Barr IG; Chow VTK; Lee VJ; Lin C; Lin R; Sadarangani SP; Young B; Chen MI
    Clin Infect Dis; 2017 Nov; 65(11):1905-1913. PubMed ID: 29028950
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada.
    Baz M; Papenburg J; Hamelin ME; Ouakki M; Skowronski DM; De Serres G; Boivin G
    Emerg Infect Dis; 2012 Jul; 18(7):1132-4. PubMed ID: 22710312
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pandemic (H1N1) 2009 and Hajj Pilgrims who received Predeparture Vaccination, Egypt.
    Kandeel A; Deming M; Elkreem EA; El-Refay S; Afifi S; Abukela M; Earhart K; El-Sayed N; El-Gabay H
    Emerg Infect Dis; 2011 Jul; 17(7):1266-8. PubMed ID: 21762583
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Swine influenza virus antibodies in humans, western Europe, 2009.
    Gerloff NA; Kremer JR; Charpentier E; Sausy A; Olinger CM; Weicherding P; Schuh J; Van Reeth K; Muller CP
    Emerg Infect Dis; 2011 Mar; 17(3):403-11. PubMed ID: 21392430
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities.
    Griffin MR; Monto AS; Belongia EA; Treanor JJ; Chen Q; Chen J; Talbot HK; Ohmit SE; Coleman LA; Lofthus G; Petrie JG; Meece JK; Hall CB; Williams JV; Gargiullo P; Berman L; Shay DK;
    PLoS One; 2011; 6(8):e23085. PubMed ID: 21857999
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effectiveness of pandemic H1N1-2009 vaccination in reducing laboratory confirmed influenza infections among military recruits in tropical Singapore.
    Lee VJ; Tan CH; Yap J; Cook AR; Ting PJ; Loh JP; Gao Q; Chen MI; Kang WL; Tan BH; Tambyah PA
    PLoS One; 2011; 6(10):e26572. PubMed ID: 22053196
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans.
    Jung J; Mundle ST; Ustyugova IV; Horton AP; Boutz DR; Pougatcheva S; Prabakaran P; McDaniel JR; King GR; Park D; Person MD; Ye C; Tan B; Tanno Y; Kim JE; Curtis NC; DiNapoli J; Delagrave S; Ross TM; Ippolito GC; Kleanthous H; Lee J; Georgiou G
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196304
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A case report of a patient in whom antibodies against the 2009 pandemic influenza A/H1N1 virus have been present since June 1999.
    Yoshida M; Sugino H; Iizuka T; Xiaofang L; Suzuki A; Oshitani H; Suzutani T; Ikuta K
    Hum Vaccin Immunother; 2013 May; 9(5):989-92. PubMed ID: 23324591
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Novel correlates of protection against pandemic H1N1 influenza A virus infection.
    Ng S; Nachbagauer R; Balmaseda A; Stadlbauer D; Ojeda S; Patel M; Rajabhathor A; Lopez R; Guglia AF; Sanchez N; Amanat F; Gresh L; Kuan G; Krammer F; Gordon A
    Nat Med; 2019 Jun; 25(6):962-967. PubMed ID: 31160818
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.
    Bodewes R; de Mutsert G; van der Klis FR; Ventresca M; Wilks S; Smith DJ; Koopmans M; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Clin Vaccine Immunol; 2011 Mar; 18(3):469-76. PubMed ID: 21209157
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum.
    Sperling RS; Engel SM; Wallenstein S; Kraus TA; Garrido J; Singh T; Kellerman L; Moran TM
    Obstet Gynecol; 2012 Mar; 119(3):631-9. PubMed ID: 22353963
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cross-reactive humoral responses to influenza and their implications for a universal vaccine.
    Chiu C; Wrammert J; Li GM; McCausland M; Wilson PC; Ahmed R
    Ann N Y Acad Sci; 2013 Apr; 1283():13-21. PubMed ID: 23405860
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cross sectional survey of influenza antibodies before and during the 2009 pandemic in Shenzhen, China.
    Wu CL; Lu J; Wang MH; Lv X; Chen Y; Kung HF; Zee B; Cheng XW; He ML
    PLoS One; 2013; 8(1):e53847. PubMed ID: 23382854
    [TBL] [Abstract][Full Text] [Related]  

  • 100. IFITM3 affects the level of antibody response after influenza vaccination.
    Lei N; Li Y; Sun Q; Lu J; Zhou J; Li Z; Liu L; Guo J; Qin K; Wang H; Zhao J; Li C; Sun L; Wang D; Zhao Z; Shu Y
    Emerg Microbes Infect; 2020 Dec; 9(1):976-987. PubMed ID: 32321380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.